The CEO decided to hold off on announcing anything before including everyone, all 1600 employees in Roche Diagnostics, in engaging in the strategy development process, in getting their views on where the company should play and how it should win in the future. Frank Desiere, VP Strategy and Business Development, Roche Diagnostics CPS now faced a dilemma. After all of the discussions and decisions made in 2017 based on the approach he facilitated, how was he going to engage 1600 people in developing the strategy, when the strategy had already been developed?
Learning Objective
- Cascading strategy development to as wide an audience as possible – given that strategy development in the past has been typically performed in a small group. The participants learn how to create such a journey.
Keywords
Strategy, Inclusive Leadership, Strategy Development, Strategic Planning, Strategy Alignment
Settings
World/global, Switzerland
Roche Holding, Healthcare
2017 - 2018
Available Languages
English
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.
Copyright Information
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
This case study is part of a series
-
Roche Diagnostics: Strategy development (A)
-
Roche Diagnostics: Strategy development (B)
-
Roche Diagnostics: Strategy development (C)